Sandra Nagel on Two Ways to Get Your Medicare Benefits

Thank you for this discussion of the basics. As this is a newsletter for those who receive immunoglobulin therapy, however, it would be particularly helpful for information that focuses on contrasting traditional Medicare and Medicare Advantage coverage of common IgG infusion solutions and methods (IV versus subQ and hospital versus home infusion). For example, I have heard that some patients who opted for Medicare Advantage coverage have found themselves unable to pay for treatment when the private insurers abruptly changed relevant copays. Any insights or factors to consider regarding IgG infusion coverage would likely be appreciated by many of us reaching retirement age.